Skip to content

Choosing the most efficient and cost-effective treatment for acute whiplash associated disorders (WAD)

A randomised three-group study, internet-based, face-to-face based and standard-management after acute whiplash associated disorders (WAD): choosing the most efficient and cost-effective treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN61531337
Enrollment
180
Registered
2009-03-27
Start date
2006-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute whiplash associated disorders Injury, Occupational Diseases, Poisoning Dislocation, sprain and strain of joints and ligaments at neck level

Interventions

Group 1: The new IT-based treatment (internet/e-mail) regimen for acute WAD patients, emphases self-monitoring and skills training, as well as discussions led by a therapist Group 2: Face-to-face inte

Sponsors

The Swedish Research Council (Sweden)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 65 years, either sex 2. Satisfactory Swedish language skills 3. Fulfill criteria for the diagnosis of WAD grade I and II 4. Ongoing pain in the neck due to the accident 5. Access to a computer

Exclusion criteria

Exclusion criteria: 1. Prior neck injury 2. Other ongoing chronic pain problems 3. Ongoing treatment for pain or pain related symptoms

Design outcomes

Primary

MeasureTime frame
1. Disability, measured with Pain Disability Index 2. Cost-effectiveness, evaluated with a cost-diary Measured at pre-, post-treatment, 3, 6, 12, 24 months follow-ups.

Secondary

MeasureTime frame
1. The Patient Goal Priority Questionnaire (PGPQ) 2. Tampa Scale for Kinesiophopia 3. Pain Intensity Diary 4. Self-Efficacy Scale 5. Coping Strategies Questionnaire 6. 36-item short form health survey (SF-36) 7. Exercise diary Measured at pre-, post-treatment, 3, 6, 12, 24 months follow-ups. QALYs are measured at 12 and 24 years follow-up.

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 2, 2026